1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow DDMS: new trials by email Literature Review of DDMS trials Research Report on DDMS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema Octreotide (drug), Placebo - Diabetic Macular Edema | Phase 1 | Withdrawn | University of Alabama at Birmingham | 2026-08-31 | 2026-10-13 | |
| LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors Lerapolturev, 5% DDM - Solid Tumor, Bladder Cancer | Phase 1 / Phase 2 | Terminated | Istari Oncology, Inc. | 4 | 2021-08-01 | 2024-10-24 |
Diabetic Retinopathy (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Urinary Bladder Neoplasms (1)
Istari Oncology, Inc. (1) · University of Alabama at Birmingham (1)
United States (2)
Lisa Franklin (1) · Maria Grant, MD, FARVO (1)